Loading…
PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population
The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population. PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphis...
Saved in:
Published in: | Journal of the Pakistan Medical Association 2020-12, Vol.70 (12(B)), p.2310-2315 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2315 |
container_issue | 12(B) |
container_start_page | 2310 |
container_title | Journal of the Pakistan Medical Association |
container_volume | 70 |
creator | Sunnetcioglu, Aysel Berkoz, Mehmet Yildirim, Metin Bora, Gulhan Yalin, Serap |
description | The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population.
PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods, respectively.
4G allele frequency was 0.62 and 0.39 for COPD and control groups, respectively. 4G allele had an estimated 2.56- fold [95% CI = 1.85-3.53] increased risk of COPD. tPA I allele frequency was 0.55 and 0.50, for COPD and control groups, respectively. I allele had an estimated 1.19-fold [95% CI = 0.87-1.62] increased risk of COPD.
PAI-1 4G/4G and 4G/5G genotypes seemed to play a key role in the pathophysiology of COPD in Turkish individuals. |
doi_str_mv | 10.5455/JPMA.250 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2479726840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2479726840</sourcerecordid><originalsourceid>FETCH-LOGICAL-p564-fb5e1d52b038b18270c3d13f2d838a09a02c88f4d475393d2484d0b3c8502e863</originalsourceid><addsrcrecordid>eNo1kD1PwzAQhj2AaClI_ALkkSXl4o_EGaMKSlERHbpHduxQQxKH2EHqwm_HgjLd8D53r55D6CaFJWec3z_vXsol4XCG5gAUkqIQZIYuvX8HIBkHuEAzSlnOOWVz9L0rN0mKZa9x2JX4zfQGD649dm4cDtZ3_jfyk6_NEKyyrQ1HHByuD6PrbY2d8mGc6mC_4t7Udq6X4xFr6430BtseS-xlN7QGuwbvp_HD-kMsiKgM1vVX6LyRrTfXp7lA-8eH_eop2b6uN6tymww8Y0mjuEk1JwqoUKkgOdRUp7QhWlAhoZBAaiEapqMVLagmTDANitaCAzEiowt093d2GN3nZHyoOhuN2lb2xk2-IiwvcpIJBhG9PaGT6oyuhtF2Uan6fxn9AbW-a4o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2479726840</pqid></control><display><type>article</type><title>PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population</title><source>DOAJ Directory of Open Access Journals</source><creator>Sunnetcioglu, Aysel ; Berkoz, Mehmet ; Yildirim, Metin ; Bora, Gulhan ; Yalin, Serap</creator><creatorcontrib>Sunnetcioglu, Aysel ; Berkoz, Mehmet ; Yildirim, Metin ; Bora, Gulhan ; Yalin, Serap</creatorcontrib><description>The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population.
PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods, respectively.
4G allele frequency was 0.62 and 0.39 for COPD and control groups, respectively. 4G allele had an estimated 2.56- fold [95% CI = 1.85-3.53] increased risk of COPD. tPA I allele frequency was 0.55 and 0.50, for COPD and control groups, respectively. I allele had an estimated 1.19-fold [95% CI = 0.87-1.62] increased risk of COPD.
PAI-1 4G/4G and 4G/5G genotypes seemed to play a key role in the pathophysiology of COPD in Turkish individuals.</description><identifier>ISSN: 0030-9982</identifier><identifier>DOI: 10.5455/JPMA.250</identifier><identifier>PMID: 33475534</identifier><language>eng</language><publisher>Pakistan</publisher><subject>Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Plasminogen Activator Inhibitor 1 - genetics ; Polymorphism, Genetic ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Pulmonary Disease, Chronic Obstructive - genetics ; Tissue Plasminogen Activator</subject><ispartof>Journal of the Pakistan Medical Association, 2020-12, Vol.70 (12(B)), p.2310-2315</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33475534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sunnetcioglu, Aysel</creatorcontrib><creatorcontrib>Berkoz, Mehmet</creatorcontrib><creatorcontrib>Yildirim, Metin</creatorcontrib><creatorcontrib>Bora, Gulhan</creatorcontrib><creatorcontrib>Yalin, Serap</creatorcontrib><title>PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population</title><title>Journal of the Pakistan Medical Association</title><addtitle>J Pak Med Assoc</addtitle><description>The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population.
PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods, respectively.
4G allele frequency was 0.62 and 0.39 for COPD and control groups, respectively. 4G allele had an estimated 2.56- fold [95% CI = 1.85-3.53] increased risk of COPD. tPA I allele frequency was 0.55 and 0.50, for COPD and control groups, respectively. I allele had an estimated 1.19-fold [95% CI = 0.87-1.62] increased risk of COPD.
PAI-1 4G/4G and 4G/5G genotypes seemed to play a key role in the pathophysiology of COPD in Turkish individuals.</description><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Polymorphism, Genetic</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Pulmonary Disease, Chronic Obstructive - genetics</subject><subject>Tissue Plasminogen Activator</subject><issn>0030-9982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo1kD1PwzAQhj2AaClI_ALkkSXl4o_EGaMKSlERHbpHduxQQxKH2EHqwm_HgjLd8D53r55D6CaFJWec3z_vXsol4XCG5gAUkqIQZIYuvX8HIBkHuEAzSlnOOWVz9L0rN0mKZa9x2JX4zfQGD649dm4cDtZ3_jfyk6_NEKyyrQ1HHByuD6PrbY2d8mGc6mC_4t7Udq6X4xFr6430BtseS-xlN7QGuwbvp_HD-kMsiKgM1vVX6LyRrTfXp7lA-8eH_eop2b6uN6tymww8Y0mjuEk1JwqoUKkgOdRUp7QhWlAhoZBAaiEapqMVLagmTDANitaCAzEiowt093d2GN3nZHyoOhuN2lb2xk2-IiwvcpIJBhG9PaGT6oyuhtF2Uan6fxn9AbW-a4o</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Sunnetcioglu, Aysel</creator><creator>Berkoz, Mehmet</creator><creator>Yildirim, Metin</creator><creator>Bora, Gulhan</creator><creator>Yalin, Serap</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population</title><author>Sunnetcioglu, Aysel ; Berkoz, Mehmet ; Yildirim, Metin ; Bora, Gulhan ; Yalin, Serap</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p564-fb5e1d52b038b18270c3d13f2d838a09a02c88f4d475393d2484d0b3c8502e863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Polymorphism, Genetic</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Pulmonary Disease, Chronic Obstructive - genetics</topic><topic>Tissue Plasminogen Activator</topic><toplevel>online_resources</toplevel><creatorcontrib>Sunnetcioglu, Aysel</creatorcontrib><creatorcontrib>Berkoz, Mehmet</creatorcontrib><creatorcontrib>Yildirim, Metin</creatorcontrib><creatorcontrib>Bora, Gulhan</creatorcontrib><creatorcontrib>Yalin, Serap</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the Pakistan Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sunnetcioglu, Aysel</au><au>Berkoz, Mehmet</au><au>Yildirim, Metin</au><au>Bora, Gulhan</au><au>Yalin, Serap</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population</atitle><jtitle>Journal of the Pakistan Medical Association</jtitle><addtitle>J Pak Med Assoc</addtitle><date>2020-12</date><risdate>2020</risdate><volume>70</volume><issue>12(B)</issue><spage>2310</spage><epage>2315</epage><pages>2310-2315</pages><issn>0030-9982</issn><abstract>The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population.
PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods, respectively.
4G allele frequency was 0.62 and 0.39 for COPD and control groups, respectively. 4G allele had an estimated 2.56- fold [95% CI = 1.85-3.53] increased risk of COPD. tPA I allele frequency was 0.55 and 0.50, for COPD and control groups, respectively. I allele had an estimated 1.19-fold [95% CI = 0.87-1.62] increased risk of COPD.
PAI-1 4G/4G and 4G/5G genotypes seemed to play a key role in the pathophysiology of COPD in Turkish individuals.</abstract><cop>Pakistan</cop><pmid>33475534</pmid><doi>10.5455/JPMA.250</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0030-9982 |
ispartof | Journal of the Pakistan Medical Association, 2020-12, Vol.70 (12(B)), p.2310-2315 |
issn | 0030-9982 |
language | eng |
recordid | cdi_proquest_miscellaneous_2479726840 |
source | DOAJ Directory of Open Access Journals |
subjects | Gene Frequency Genetic Predisposition to Disease Genotype Humans Plasminogen Activator Inhibitor 1 - genetics Polymorphism, Genetic Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonary Disease, Chronic Obstructive - genetics Tissue Plasminogen Activator |
title | PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A51%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PAI-1%20and%20tPA%20gene%20polymorphisms%20and%20susceptibility%20to%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20sample%20of%20Turkish%20population&rft.jtitle=Journal%20of%20the%20Pakistan%20Medical%20Association&rft.au=Sunnetcioglu,%20Aysel&rft.date=2020-12&rft.volume=70&rft.issue=12(B)&rft.spage=2310&rft.epage=2315&rft.pages=2310-2315&rft.issn=0030-9982&rft_id=info:doi/10.5455/JPMA.250&rft_dat=%3Cproquest_pubme%3E2479726840%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p564-fb5e1d52b038b18270c3d13f2d838a09a02c88f4d475393d2484d0b3c8502e863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2479726840&rft_id=info:pmid/33475534&rfr_iscdi=true |